SVRA
Savara Inc. NASDAQ Listed Apr 28, 2017$5.16
Mkt Cap $1.1B
52w Low $1.89
63.9% of range
52w High $7.00
50d MA $5.43
200d MA $4.73
P/E (TTM)
-9.7x
EV/EBITDA
-10.8x
P/B
5.6x
Debt/Equity
0.1x
ROE
-58.5%
P/FCF
-13.3x
RSI (14)
—
ATR (14)
—
Beta
0.31
50d MA
$5.43
200d MA
$4.73
Avg Volume
1.6M
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
CIK (SEC)
Phone
512 614 1848
Building III · Langhorne, TX 78746 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | AMC | -0.12 | -0.13 | -8.3% | 5.25 | +1.3% | -0.4% | -1.5% | -2.1% | +2.4% | -3.9% | — |
| Nov 12, 2025 | AMC | -0.13 | -0.14 | -7.7% | 4.12 | +0.5% | +3.4% | +0.9% | -2.3% | -0.7% | +10.3% | — |
| Aug 13, 2025 | AMC | -0.12 | -0.14 | -16.7% | 2.70 | +0.0% | +11.5% | +1.0% | +0.3% | +0.0% | +1.3% | — |
| May 13, 2025 | AMC | -0.12 | -0.12 | +0.0% | 2.97 | -0.7% | +0.7% | +4.0% | -1.3% | +2.0% | +0.3% | — |
| Mar 27, 2025 | AMC | -0.11 | -0.13 | -18.2% | 2.78 | +2.5% | +4.7% | -4.8% | +3.2% | +5.2% | -3.7% | — |
| Nov 12, 2024 | AMC | -0.11 | -0.11 | +0.0% | 3.83 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% | — |
| Aug 12, 2024 | AMC | -0.11 | -0.12 | -9.1% | 4.10 | +2.4% | +1.0% | +2.9% | +5.9% | -3.5% | +2.3% | — |
| May 9, 2024 | AMC | -0.10 | -0.11 | -10.0% | 5.07 | -3.2% | -8.1% | -1.5% | +4.8% | +0.4% | -2.3% | — |
| Mar 7, 2024 | AMC | -0.11 | -0.09 | +18.2% | 5.59 | -2.1% | -5.2% | -7.4% | +0.2% | -0.6% | -4.7% | — |
| Nov 9, 2023 | AMC | -0.07 | -0.10 | -42.9% | 3.41 | +7.2% | +1.8% | -0.3% | +6.4% | -0.5% | -1.5% | — |
| Aug 10, 2023 | AMC | -0.08 | -0.07 | +12.5% | 3.84 | +1.6% | +1.0% | -1.5% | +1.0% | -8.0% | -3.1% | — |
| May 15, 2023 | AMC | -0.07 | -0.07 | +0.0% | 1.98 | +6.1% | +9.1% | +14.8% | +3.2% | +2.3% | -1.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Oppenheimer | Reiterates | Outperform | $11 | $4.94 | $4.97 | +0.6% | +3.6% | +0.8% | -2.7% | -3.4% | +8.0% |
| Dec 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.47 | $6.56 | +1.4% | -0.5% | -0.6% | +0.8% | -1.9% | -3.5% |
| Dec 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $6.11 | $6.24 | +2.1% | -0.8% | -0.2% | +6.9% | -0.5% | -0.6% |
| Nov 14 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.26 | $4.32 | +1.4% | +0.9% | -2.3% | -0.7% | +10.3% | +1.5% |
| Nov 13 | Citizens | Maintains | Market Outperform → Market Outperform | — | $4.12 | $4.14 | +0.5% | +3.4% | +0.9% | -2.3% | -0.7% | +10.3% |
| Oct 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.11 | $4.20 | +2.2% | +0.2% | +5.8% | +0.5% | +0.7% | -1.6% |
| Sep 9 | Guggenheim | Maintains | Buy → Buy | — | $3.85 | $3.81 | -1.0% | -0.8% | +0.3% | -6.3% | -0.8% | +1.4% |
| Sep 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.72 | $3.85 | +3.5% | +3.5% | -0.8% | +0.3% | -6.3% | -0.8% |
| Sep 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.31 | $3.36 | +1.5% | +3.3% | +4.7% | +3.9% | +3.5% | -0.8% |
| Aug 15 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $3.01 | $3.28 | +9.0% | +1.0% | +0.3% | +0.0% | +1.3% | -1.3% |
| Aug 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.01 | $3.28 | +9.0% | +1.0% | +0.3% | +0.0% | +1.3% | -1.3% |
| Jun 1 | Oppenheimer | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| May 29 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $2.13 | $1.99 | -6.6% | +5.2% | +1.8% | +5.3% | +0.0% | +3.8% |
| May 28 | Evercore ISI | Maintains | In Line → In Line | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| May 28 | Guggenheim | Maintains | Buy → Buy | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| May 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| Mar 31 | Evercore ISI | Maintains | In Line → Hold | — | $2.91 | $2.81 | -3.4% | -4.8% | +3.2% | +5.2% | -3.7% | -1.7% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.78 | $2.85 | +2.5% | +4.7% | -4.8% | +3.2% | +5.2% | -3.7% |
| Dec 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $3.02 | $3.09 | +2.3% | +7.0% | +0.0% | +0.6% | -1.5% | +2.5% |
| Nov 13 | Evercore ISI | Downgrade | Outperform → In Line | — | $3.83 | $3.67 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.83 | $3.67 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% |
| Oct 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.74 | $3.71 | -0.8% | +1.1% | -3.4% | -1.4% | +4.7% | -2.9% |
| Oct 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.24 | $4.20 | -0.9% | -5.9% | -2.3% | -2.3% | +0.3% | -2.1% |
| Oct 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.24 | $4.20 | -0.9% | -5.9% | -2.3% | -2.3% | +0.3% | -2.1% |
| Sep 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.42 | $4.36 | -1.4% | -3.6% | +3.3% | -1.8% | -1.9% | -0.9% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.14 | $4.20 | +1.4% | +2.9% | +5.9% | -3.5% | +2.3% | +1.1% |
| Aug 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.10 | $4.20 | +2.4% | +1.0% | +2.9% | +5.9% | -3.5% | +2.3% |
| Jun 27 | Guggenheim | Maintains | Buy → Buy | — | $3.84 | $3.85 | +0.3% | -0.8% | +5.8% | +15.1% | -7.3% | +0.7% |
| Jun 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.84 | $3.85 | +0.3% | -0.8% | +5.8% | +15.1% | -7.3% | +0.7% |
| Jun 26 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.80 | $4.42 | +16.3% | +1.1% | -0.8% | +5.8% | +15.1% | -7.3% |
| May 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.17 | $4.22 | +1.2% | +3.1% | +0.7% | -3.7% | -2.2% | +1.7% |
| May 16 | Evercore ISI | Maintains | Outperform → Outperform | — | $4.83 | $4.77 | -1.2% | -2.3% | -5.1% | -6.9% | +3.1% | +0.7% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.66 | $4.64 | -0.4% | -1.5% | +4.8% | +0.4% | -2.3% | -5.1% |
| May 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.71 | $4.74 | +0.6% | +5.1% | +6.3% | -5.1% | +1.6% | -8.1% |
| Apr 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.79 | $4.75 | -0.8% | +0.4% | -2.3% | -0.2% | -9.6% | +5.0% |
| Apr 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.96 | $4.95 | -0.2% | -3.4% | +0.4% | -2.3% | -0.2% | -9.6% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.30 | $5.29 | -0.2% | -7.4% | +0.2% | -0.6% | -4.7% | +1.1% |
| Mar 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.16 | $5.26 | +1.9% | +6.8% | -1.5% | -0.2% | +3.1% | -5.2% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.47 | $3.47 | +0.0% | -0.3% | +6.4% | -0.5% | -1.5% | +3.5% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.88 | $3.97 | +2.3% | -1.5% | +1.0% | -8.0% | -3.1% | +2.9% |
| May 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.16 | +0.0% | +14.8% | +3.2% | +2.3% | -1.5% | -1.2% |
| Apr 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.83 | $1.82 | -0.5% | -6.6% | -1.2% | +1.8% | +0.0% | +0.6% |
| Apr 3 | Jefferies | Downgrade | Buy → Hold | — | $1.95 | $1.92 | -1.5% | -6.2% | -6.6% | -1.2% | +1.8% | +0.0% |
| Mar 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $1.77 | $2.25 | +27.1% | +15.8% | +13.7% | -8.6% | -2.8% | -6.3% |
| Mar 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $1.57 | $1.75 | +11.5% | +12.7% | +15.8% | +13.7% | -8.6% | -2.8% |
| Dec 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.15 | $1.11 | -3.5% | +8.7% | -1.6% | +4.9% | +5.4% | +0.0% |
| Jun 13 | JMP Securities | Downgrade | Outperform → Market Perform | — | $10.57 | $2.67 | -74.7% | -75.2% | -6.1% | -3.3% | +0.0% | +13.9% |
| Jun 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $9.42 | $10.85 | +15.2% | +21.1% | +0.2% | +4.6% | +1.3% | +3.0% |
| May 25 | H.C. Wainwright | Maintains | Buy → Buy | — | $8.55 | $8.99 | +5.1% | +3.9% | +17.6% | +4.1% | -6.9% | -4.2% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $8.60 | $8.60 | +0.0% | +7.9% | +0.3% | -0.9% | +0.2% | +1.8% |
No insider trades available.
Data updated apr 27, 2026 3:39am
· Source: massive.com